Target intelligence / Profile preview

Non-specific skin barrier and inflammatory mediators

Molecular classification
Other
01

Overview

The category 'Non-specific skin barrier and inflammatory mediators' refers to a broad physiological complex rather than a single molecular target. The skin barrier, primarily the stratum corneum, serves as the body's first line of defense against environmental pathogens and prevents excessive transepidermal water loss, often maintained by proteins like filaggrin and lipids like ceramides (StatPearls, 2023). Free radicals, or reactive oxygen species (ROS), are highly reactive molecules generated by UV exposure or metabolic processes that can cause oxidative damage to cellular DNA and lipids (NIH, 2022). Inflammatory mediators, including cytokines such as IL-1 and TNF-alpha, are signaling molecules released in response to barrier disruption or oxidative stress to coordinate an immune response (PubMed, 2021). Therapeutic interventions targeting this complex are multi-factorial, utilizing emollients to restore barrier integrity, antioxidants to quench free radicals, and anti-inflammatory agents to mitigate tissue damage. Because this grouping encompasses a wide array of lipids, proteins, and small molecules, it is considered a non-specific therapeutic focus rather than a canonical drug target.

Other names
Skin barrier componentsReactive oxygen species (ROS)Pro-inflammatory cytokinesDermal defense systemOxidative stress and inflammatory markers
02

Mechanism of action

Physical occlusion of the stratum corneum, replenishment of intercellular lipids, neutralization of reactive oxygen species through electron donation, and inhibition of cyclooxygenase or cytokine signaling pathways.

03

Biological functions

Barrier functionOxidative stress responseImmune responseHomeostasis
04

Disease associations

Atopic dermatitisPsoriasisPhotoagingContact dermatitisInflammation
05

Safety considerations

Skin irritationSystemic absorption of topical agentsRebound inflammationPotential pro-oxidant effects at high concentrations
06

Interacting drugs

Petrolatum

5 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Malondialdehyde (MDA)C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)

Beyond the preview

Go deeper on Non-specific skin barrier and inflammatory mediators.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-specific skin barrier and inflammatory mediators.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call